Etodolac: Targeted Relief for Chronic Pain and Inflammation
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.85 | $51.26 (0%) | 🛒 Add to cart |
| 90 | $0.77 | $76.89 $69.35 (10%) | 🛒 Add to cart |
| 120 | $0.73 | $102.52 $87.44 (15%) | 🛒 Add to cart |
| 180 | $0.69 | $153.78 $123.63 (20%) | 🛒 Add to cart |
| 270 | $0.66 | $230.67 $177.90 (23%) | 🛒 Add to cart |
| 360 | $0.65
Best per pill | $307.56 $233.18 (24%) | 🛒 Add to cart |
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.54 | $46.23 (0%) | 🛒 Add to cart |
| 60 | $1.22 | $92.47 $73.37 (21%) | 🛒 Add to cart |
| 90 | $1.11 | $138.70 $99.51 (28%) | 🛒 Add to cart |
| 120 | $1.05 | $184.94 $125.64 (32%) | 🛒 Add to cart |
| 180 | $0.99 | $277.41 $178.91 (36%) | 🛒 Add to cart |
| 270 | $0.96 | $416.11 $258.31 (38%) | 🛒 Add to cart |
| 360 | $0.94
Best per pill | $554.82 $336.71 (39%) | 🛒 Add to cart |
| Product dosage: 400mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.31 | $69.35 (0%) | 🛒 Add to cart |
| 60 | $1.83 | $138.70 $109.56 (21%) | 🛒 Add to cart |
| 90 | $1.66 | $208.06 $149.76 (28%) | 🛒 Add to cart |
| 120 | $1.58 | $277.41 $189.96 (32%) | 🛒 Add to cart |
| 180 | $1.50 | $416.11 $270.37 (35%) | 🛒 Add to cart |
| 270 | $1.45
Best per pill | $624.17 $391.99 (37%) | 🛒 Add to cart |
Synonyms | |||
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) specifically formulated to provide effective management of pain and inflammation associated with osteoarthritis and rheumatoid arthritis. As a prescription medication, it functions by inhibiting the body’s production of prostaglandins, substances that contribute to inflammation, pain, and fever. Its targeted action offers a balance of potent efficacy and a well-characterized safety profile when used as directed under medical supervision. This makes it a valuable option in long-term therapeutic regimens for chronic musculoskeletal conditions.
Features
- Active ingredient: Etodolac
- Available in tablet and extended-release tablet formulations
- Prescription-only medication
- Selective COX-2 inhibitor with some COX-1 activity
- Multiple strengths available (e.g., 400 mg, 500 mg, 600 mg tablets; 400 mg, 500 mg, 600 mg extended-release)
- Typically administered once or twice daily depending on formulation
Benefits
- Provides significant reduction in joint pain and stiffness
- Decreases inflammation and swelling in affected joints
- Improves physical function and mobility in arthritic conditions
- Offers sustained relief with extended-release formulations
- May allow for reduced dependence on adjunct analgesic medications
- Well-established efficacy profile in chronic pain management
Common use
Etodolac is primarily indicated for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. It is used to reduce pain, inflammation, and stiffness in affected joints, thereby improving patients’ quality of life and functional capacity. Healthcare providers may also prescribe it off-label for other painful inflammatory conditions when appropriate, though such use should be carefully monitored. The medication is typically incorporated into a comprehensive treatment plan that may include physical therapy, lifestyle modifications, and other therapeutic interventions.
Dosage and direction
For osteoarthritis and rheumatoid arthritis, the recommended initial dosage for immediate-release tablets is 300 mg twice daily or 400 mg twice daily. Alternatively, 500 mg twice daily may be used. For maintenance therapy, doses from 600 mg to 1000 mg daily divided into two doses may be used. For extended-release tablets, the recommended dosage is 400 mg to 1000 mg once daily. The lowest effective dose should be used for the shortest duration consistent with individual treatment goals. Tablets should be swallowed whole with a full glass of water, preferably with food or milk to minimize gastrointestinal upset. Dosage adjustments may be necessary for elderly patients, those with renal impairment, or those taking concomitant medications.
Precautions
Patients should be monitored for signs of gastrointestinal ulceration and bleeding, especially those with a history of peptic ulcer disease. Renal function should be assessed periodically during long-term therapy, particularly in elderly patients or those with pre-existing renal impairment. Hepatic function should be monitored in patients receiving long-term treatment. Caution is advised in patients with hypertension, heart failure, or other cardiovascular risk factors. Patients should be advised to avoid alcohol consumption during therapy as it may increase the risk of gastrointestinal bleeding. Use with caution in patients with asthma, especially those with aspirin-sensitive asthma, as NSAIDs may cause severe bronchospasm.
Contraindications
Etodolac is contraindicated in patients with known hypersensitivity to etodolac or any components of the formulation. It should not be used in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Contraindicated in the setting of coronary artery bypass graft (CABG) surgery. Should not be used in patients with a history of prostaglandin-sensitive asthma. Contraindicated in patients with active peptic ulcer disease or recent gastrointestinal bleeding. Not recommended for patients with severe heart failure, advanced renal disease, or severe hepatic impairment.
Possible side effect
Common side effects may include dyspepsia (10%), abdominal pain (8%), nausea (9%), diarrhea (9%), flatulence (3%), and headache (4%). Less frequently, patients may experience dizziness, rash, edema, tinnitus, or elevated liver enzymes. Serious side effects requiring immediate medical attention include signs of gastrointestinal bleeding (black tarry stools, vomiting blood), symptoms of heart problems (chest pain, shortness of breath, weakness on one side of the body), signs of kidney problems (change in amount of urine), severe skin reactions, or allergic reactions (swelling of face/throat, difficulty breathing). Long-term use may increase the risk of heart attack or stroke.
Drug interaction
Etodolac may interact with anticoagulants like warfarin, increasing the risk of bleeding. Concurrent use with other NSAIDs or aspirin may increase the risk of gastrointestinal adverse effects. May reduce the antihypertensive effect of ACE inhibitors, angiotensin II receptor blockers, and beta-blockers. Can increase lithium levels and risk of lithium toxicity. May enhance the nephrotoxic potential of cyclosporine. Diuretics may have reduced effectiveness when used concomitantly with etodolac. Methotrexate levels may be increased, potentially leading to toxicity. Corticosteroids may increase the risk of gastrointestinal ulceration. SSRIs may increase the risk of gastrointestinal bleeding.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. If multiple doses are missed or uncertainty exists about dosing, patients should contact their healthcare provider for guidance. Maintaining consistent blood levels is important for optimal therapeutic effect, particularly in managing chronic inflammatory conditions.
Overdose
Symptoms of overdose may include nausea, vomiting, epigastric pain, gastrointestinal bleeding, drowsiness, lethargy, tinnitus, and respiratory depression. In severe cases, acute renal failure, liver damage, hypertension, metabolic acidosis, coma, or convulsions may occur. Management is supportive and symptomatic. There is no specific antidote. Gastric lavage or activated charcoal may be considered if presented soon after ingestion. Forced diuresis, alkalinization of urine, hemodialysis, or hemoperfusion are unlikely to be beneficial due to high protein binding. Patients should seek immediate medical attention or contact a poison control center if overdose is suspected.
Storage
Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Keep in the original container, tightly closed, and protect from moisture and light. Keep out of reach of children and pets. Do not store in bathroom areas where moisture levels may be higher. Properly discard any medication that is outdated or no longer needed. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Consult with a pharmacist about proper disposal methods.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual responses to medication may vary. This is not a complete discussion of all possible risks, side effects, or interactions. Patients should always consult with a qualified healthcare professional before starting, stopping, or changing any medication regimen. Only a healthcare provider familiar with a patient’s specific medical history can provide appropriate medical advice and determine whether etodolac is suitable for their condition.
Reviews
Clinical studies have demonstrated etodolac’s efficacy in managing arthritis symptoms, with many patients reporting significant improvement in pain scores and functional assessments. In comparative trials, etodolac has shown similar efficacy to other NSAIDs with a potentially favorable gastrointestinal tolerance profile. Patient reviews often note effective pain relief and improved mobility, though some report gastrointestinal side effects. Many rheumatologists consider it a valuable option in the NSAID class, particularly for long-term management of chronic inflammatory conditions. As with all NSAIDs, individual response varies, and careful patient selection and monitoring are essential for optimal outcomes.